Healthline: Controversial studies find COVID-19 may be far more widespread than previously known
UC expert says lack of testing could be a factor
Healthline interviewed Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases for a news story on two studies in California finding that COVID-19 may be much more widespread than previously thought.
Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases. Photo/Colleen Kelley/UC Creative + Brand
Fichtenbaum said one of the reasons for the discrepancy was a lack of testing.
“Because testing for the virus is not widely available due to lack of supplies, reagents, and machines, it’s not surprising that a sero-epidemiologic survey would find more individuals with infection,” Fichtenbaum said.
Read the entire article here.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.